Increased LINC00511 expression level significantly correlated with worse prognosis and higher incidence of lymph node metastasis in patients with malignant tumors, indicating that LINC00511 may be a prognostic biomarker and therapeutic target. The gene discussed is LINC00511; the disease is cancer.